Business

Glaxo Sells Rights to Auto-Immune Drug to Novartis

LONDON (MarketWatch) – GlaxoSmithKline PLC is selling its remaining rights to a drug for use in treating autoimmune diseases, including multiple sclerosis, to Novartis AG for up to $1 billion, plus royalties. Glaxo said on Friday that Novartis will own rights to ofatumumab, as the Read More

Advertisements
Health

MS, Psoriasis Drugs and Deadly Brain Infections

(HealthDay News) — An active ingredient in some psoriasis and multiple sclerosis medications has been linked to two cases of a rare and sometimes lethal brain infection. The ingredient, dimethyl fumarate, appears to have contributed to the deaths of two European women. The women contracted progressive multifocal leukoencephalopathy, or Read More